Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Acquisition

15 Sep 2008 07:00

RNS Number : 3928D
First Derivatives PLC
15 September 2008
 

15 September 2008

First Derivatives plc 

(AIM:FDP.L, IEX:GYQ.I)

Acquisition of Market Resource Partners

The Board of First Derivatives plc ("First Derivatives" or the "Company") announces that it has acquired Market Resource Partners LLC ("MRP"), a US based technology marketing company headquartered in Philadelphia, PA, for a total consideration of up to $20 million (£11.3m) (the "Acquisition"). The Acquisition comprises an initial cash payment of $4.5m (£2.5m) and a further $1.5m (£0.8m) through the issue of 436,644 First Derivatives new ordinary shares (the "Consideration Shares"). An additional deferred consideration of up to a maximum of $14m (£7.9m) (will be payable, subject to MRP achieving certain profit goals during the two years ending 31 August 2010. The initial cash consideration will be financed from the Company's existing bank facilities.

Founded in 2002, MRP specializes in the strategic development and tactical execution of marketing and sales programs for software and technology service firms. Utilizing MRP's strategic consulting and predictive analytics, clients are in a position to make more informed decisions leading to immediate and longer term sales opportunities. MRP's clients comprise technology firms, Independent Software Vendors and channel resellers including Microsoft, Sun Microsystems and Cisco Systems. MRP employs 95 people in its office in Philadelphia, PA.

MRP achieved an EBITDA of $838,000 (£474,000) in the 12 months to 31 December 2006 and EBITDA of $335,000 (£190,000) in the 12 months to 31 December 2007 after adjusting for one-off costs of $163,000 (£92,000) from relocating their head office. In the six months to 30 June 2008 MRP achieved EBITDA of $653,000 (£369,000). The vendors have warranted that MRP's net assets as at 31 August 2008 (the effective date of the transaction) were not less than $200,000 (£113,000).

The Acquisition enhances First Derivatives presence in its largest market and will help accelerate the Company's expansion into the US by enhancing its global support offering. MRP will also provide another channel to market, for the Company's products, not only to the financial sector but also to other market segments.

The Consideration Shares will rank pari passu with the Company's existing ordinary shares. Application will be made for the Consideration Shares to be admitted to trading on AIM and the IEX and dealings are expected to commence on 19 September 2008. Following Admission the enlarged issued share capital of the Company will be 13,720,468 Ordinary Shares.

First Derivatives' CEO Brian Conlon said: "MRP is one of the leaders in its field and the continuing loyalty of its customer base, which is a roll call of the world's leading technology firms, is testimony to the quality of service it provides. This transaction represents a coming together of two very like minded firms with a mutual emphasis on professionalism and customer-driven innovation.

This Acquisition gives us access to an established team of world class technology marketing professionals. We have invested significant resources in R&D and this accelerates our channel to market particularly in the U.S. and into sectors other than investment banking. The investment will also provide a springboard for establishing a greater presence in the US market and will enable us to replicate our successful nearshore model in North America"

Kevin Cunningham of MRP said "We are excited about the opportunities that this transaction provides for MRP, our clients, and our employees. It allows us to accelerate the build out of our technology infrastructure and analytic capabilities, giving us the operational scale to meet our increasingly complex client needs. It also enables us to expand further our European operations and expertise in the financial technology sector, opening up new, more diverse business opportunities for MRP."

Contact:

First Derivatives plc

Brian Conlon

Michael O'Neill

Tel: +44 (0)28 3025 2242

Charles Stanley Securities

Nominated Adviser

Russell Cook/Carl Holmes

Tel: +44 (0)20 7149 6000

Goodbody Corporate Finance 

IEX Adviser

Finbarr Griffin/ Diane Hodgson

Tel: +353 1 667 0420

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQGUUPWBUPRGAC
Date   Source Headline
12th Oct 20207:00 amRNSNotice of Results
30th Sep 20204:27 pmRNSTotal Voting Rights
16th Sep 20207:00 amRNSDirectorate Change
2nd Sep 20203:54 pmRNSIssue of Equity
2nd Sep 20207:00 amRNSTotal Voting Rights
26th Aug 20208:46 amRNSIssue of Equity
20th Aug 20206:10 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSEuronext Growth Dublin Notice
31st Jul 202012:01 pmRNSIssue of Equity and Total Voting Rights
20th Jul 20207:00 amRNSAppointment of Kx Chief Revenue Officer
14th Jul 20207:00 amRNSDirectorate Change
9th Jul 20207:00 amRNSShare Option Plan Awards
9th Jul 20207:00 amRNSEuronext Growth Dublin Notice
8th Jul 20204:07 pmRNSResult of AGM
8th Jul 20207:00 amRNSAGM Statement
7th Jul 202012:02 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSSenior Executive Appointment
3rd Jul 202010:23 amRNSIssue of Equity
2nd Jul 20207:00 amRNSDirectorate Change
30th Jun 20202:35 pmRNSTotal Voting Rights
9th Jun 20208:00 amRNSEuronext Growth Dublin Notice
8th Jun 20204:30 pmRNSNotice of AGM
3rd Jun 20202:33 pmRNSIssue of Equity
1st Jun 202011:00 amRNSTotal Voting Rights
28th May 20207:00 amRNSEuronext Growth Dublin Notice
22nd May 20205:59 pmRNSIssue of Equity - Correction
21st May 20204:19 pmRNSIssue of Equity
19th May 20207:00 amRNSGlobal partnership agreement
19th May 20207:00 amRNSFull year results for the year ended 29 Feb 2020
9th Apr 20207:00 amRNSTrading Statement
31st Mar 202010:06 amRNSTotal Voting Rights
12th Mar 20207:00 amRNSEuronext Growth Dublin Notice
6th Mar 202010:52 amRNSIssue of Equity
17th Feb 20207:00 amRNSMajor oilfield services contract win
31st Jan 202012:01 pmRNSTotal Voting Rights
30th Jan 20207:00 amRNSEuronext Growth Dublin Notice
24th Jan 20202:01 pmRNSIssue of Equity
15th Jan 20207:00 amRNSCEO appointment and Board changes
31st Dec 20199:58 amRNSTotal Voting Rights
17th Dec 20197:00 amRNSEuronext Growth Dublin Notice
12th Dec 20197:00 amRNSEuronext Growth Dublin Notice
11th Dec 20193:10 pmRNSIssue of Equity
11th Dec 20197:50 amRNSHolding(s) in Company
6th Dec 20193:10 pmRNSIssue of Equity
29th Nov 20194:46 pmRNSTotal Voting Rights
15th Nov 20197:00 amRNSEuronext Growth Dublin Notice
8th Nov 20192:32 pmRNSIssue of Equity
5th Nov 20197:00 amRNSInterim results for the six months ended 31.08.19
1st Nov 201910:15 amRNSHolding(s) in Company
8th Oct 20197:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.